Position in EXEL
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$25,028
+$23,141 QoQ
Shares Held
460
+945.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#635
of 751 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kingdom Financial Group LLC. holds $98,119 across 10 Biotechnology names. EXEL ranks #3 (25.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
392 | $44,437 | |
| 2 | RPRX |
Royalty Pharma plc
|
492 | $27,586 | |
| 3 | EXEL |
Exelixis, Inc.
This page
|
460 | $25,028 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3 | $903 | |
| 5 | ALEC |
Alector, Inc.
|
48 | $96 | |
| 6 | BEAM |
Beam Therapeutics Inc.
|
1 | $34 | |
| 7 | BNTX |
BioNTech SE
|
0 | $30 | |
| 8 | NTLA |
Intellia Therapeutics, Inc.
|
0 | $3 |
All Filings in EXEL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,028 | 460 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,887 | 44 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||